DowDuPont To Expand Capacity To Meet DuPont Zytel HTN Demand

 | Nov 15, 2017 08:24PM ET

DowDuPont Inc.’s (NYSE:DWDP) Transportation & Advanced Polymers unit is increasing production capacity at its Mechelen, Belgium site. The latest move will address the growing demand for DuPont Zytel HTN high-performance polyamide resin used in the automotive, consumer and electronics markets.
Transportation & Advanced Polymers, a segment of DowDuPont Specialty Products Division, owns and operates world-scale polymerization and compounding assets in major regions of the world.
The Specialty Products Division has increased its investment at the Mechelen site to install a new production line that will come online in the fourth quarter of 2017. DowDuPont Transportation & Advanced Polymers continues to invest in compounding capacity expansion to address the strong growth in demand for highly engineered specialty polymers including PPAs.
Part of Zytel HTN high-performance polyamide resin portfolio, Zytel HTN PPA grades offers outstanding chemical resistance. It is also known to retain properties when exposed to moisture and can even perform at high temperature.
DowDuPont has underperformed the

Dow Chemical Company (The) Quote

Zacks Rank & Stocks to Consider

DowDuPont is a Zacks Rank #3 (Hold) stock.

Some better-ranked companies in the basic materials space are Ingevity Corporation (NYSE:NGVT) , ArcelorMittal (NYSE:MT) and Westlake Chemical Corporation (NYSE:WLK) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Ingevity has expected long-term earnings growth of 12%. Its shares have gained 33.5% year to date.

ArcelorMittal has expected long-term earnings growth of 11.3%. Its shares have rallied 27.5% year to date.

Westlake Chemical has expected long-term earnings growth of 8.4%. Its shares have moved up 61.8% year to date.

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Original post

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes